Form 4 for DGX Quest Diagnostics
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-29 · accession 0001022079-24-000208 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-02 | 2024-11-29 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $86.63 | +35.1K | 73.6K | +91% | +$3.04M |
| DM | 2024-12-02 | 2024-11-29 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $163.07 | -35.1K | 38.5K | -48% | -$5.73M |
| D | 2024-12-02 | 2024-11-29 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $86.63 | -35.1K | 0 | -100% | -$3.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | M | A | 35,146 | $86.63 | 73,624 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-29 | S | D | 3,009 | $162.26 | 70,615 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $161.690 to $162.680. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-11-29 | S | D | 32,137 | $163.15 | 38,478 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $162.705 to $163.615. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2024-11-29 | M | D | 35,146 | $86.63 | 0 | D | $86.63 · — to 2029-02-18 | 35,146 Common Stock | (F5) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |